KZIA
Kazia Therapeutics·NASDAQ
--
--(--)
--
--(--)
KZIA Filings
Filing Date
Form Description
Form Type
2026-04-01
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-04-01 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-04-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-04-01 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-03-31
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-31 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-31
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-31 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-30
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-30 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-30
Form EFFECT - Notice of Effectiveness
2026-03-30 ·
Form EFFECT - Notice of Effectiveness
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
